Table 1 Patient demographics.

From: Close negative correlation of local and circulating Dickkopf-1 and Sclerostin levels during human fracture healing

 

Fracture cohort (N = 114/100%)

Controls (N = 33/100%)

Parameter

Median (IQR)/N (%)

Median (IQR)/%

Age (years)

43.5 (32.75–58)

34.5 (29–46)

Sex

  

 Female

51.3%

55.9%

 Male

48.7%

44.1%

Fracture location

 

 Femur

19.18%

 

 Lower leg

45,86%

 

 Femur + lower leg

7.02%

 

 Humerus

20.05%

 

 Forearm

7.89%

 

Type of fixation

 

 Plate

33.33%

 

 IM

57.89%

 

 Ex. Fix

7.08%

 

 Screw

1.70%

 

Soft tissue damage

14.91%

 

Non Union (N = 7)

8.2%

 

Non osteogenic risk factors

 

 Smoking

29.6%

 

 Diabetes

14.8%

 

 Frequent alcohol intake

7.4%

 

DKK1 (pmol/L)

 

 BL

 

19.82 (16.06–26.77)

 Week 1

20.68 (16.82–31.26)

 

 Week 2

27.22 (21.92–33.77)

 

 Week 4

21.31 (17.6–27.97)

 

 Week 6

21.21 (16.59–28.93)

 

 Week 8

21.59 (17–26.52)

 

 Week 12

18.18 (14.31–24.84)

 

 Week 24

19.58 (15.15–25.9)

 

SOST (pmol/L)

 

 BL

 

8.19 (5.39–14.03)

 Week 1

15.29 (10.7–22.36)

 

 Week 2

17.81 (12.65–26.24)

 

 Week 4

20.32 (15.4–27.6)

 

 Week 6

18.32 (13.97–27.69)

 

 Week 8

21.2 (15.98–31.79)

 

 Week 12

19.95 (14.2–32.01)

 

 Week 24

18.24 (13.7–27.65)

 
  1. IM, intramedullary fixation; Ex. fix., external fixator; Soft-tissue damage 1°, type I fracture due to Gutilo classification; BL, Baseline.